Deutsche Bank Ag\ Cyma Bay Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.63 - $24.47 $11.6 Million - $22.6 Million	921,858 Added 202.11%	1,377,964 $32.5 Million
Q3 2023 Nov 09, 2023	SELL	$10.86 - $17.62 $4.02 Million - $6.52 Million	-369,851 Reduced 44.78%	456,106 $6.8 Million
Q2 2023 Aug 14, 2023	BUY	$7.47 - $10.95 $3.22 Million - $4.72 Million	430,868 Added 109.06%	825,957 $9.04 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $1.58 Million - $2.57 Million	267,893 Added 210.61%	395,089 $3.45 Million
Q2 2022 Aug 11, 2022	SELL	$1.72 - $3.39 $64,512 - $127,148	-37,507 Reduced 22.77%	127,196 $375,000
Q1 2022 May 13, 2022	SELL	$2.77 - $3.64 $12,678 - $16,660	-4,577 Reduced 2.7%	164,703 $512,000
Q4 2021 Feb 11, 2022	BUY	$3.23 - $4.6 $7,151 - $10,184	2,214 Added 1.33%	169,280 $572,000
Q3 2021 Nov 04, 2021	SELL	$3.47 - $4.42 $834,510 - $1.06 Million	-240,493 Reduced 59.01%	167,066 $610,000
Q2 2021 Aug 11, 2021	SELL	$3.94 - $4.92 $443,963 - $554,390	-112,681 Reduced 21.66%	407,559 $1.78 Million
Q1 2021 May 13, 2021	BUY	$4.23 - $6.55 $1.99 Million - $3.08 Million	469,590 Added 927.13%	520,240 $2.36 Million
Q4 2020 Feb 16, 2021	BUY	$5.73 - $9.03 $15,866 - $25,004	2,769 Added 5.78%	50,650 $291,000
Q3 2020 Nov 12, 2020	SELL	$3.32 - $7.24 $1.1 Million - $2.4 Million	-331,276 Reduced 87.37%	47,881 $347,000
Q2 2020 Aug 13, 2020	SELL	$1.41 - $4.25 $3.91 Million - $11.8 Million	-2,775,270 Reduced 87.98%	379,157 $1.32 Million
Q1 2020 May 14, 2020	BUY	$1.25 - $2.02 $3.26 Million - $5.26 Million	2,605,008 Added 474.14%	3,154,427 $4.67 Million
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $355,679 - $1.59 Million	267,428 Added 94.84%	549,419 $1.08 Million
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $920,442 - $1.3 Million	179,774 Added 175.87%	281,991 $1.44 Million
Q2 2019 Aug 14, 2019	SELL	$6.05 - $13.66 $665,288 - $1.5 Million	-109,965 Reduced 51.83%	102,217 $730,000
Q1 2019 May 15, 2019	BUY	$8.16 - $13.42 $1.22 Million - $2 Million	149,388 Added 237.9%	212,182 $2.82 Million
Q4 2018 Feb 14, 2019	SELL	$6.54 - $11.74 $598,488 - $1.07 Million	-91,512 Reduced 59.31%	62,794 $493,000
Q3 2018 Dec 21, 2021	BUY	$10.88 - $14.52 $394,944 - $527,076	36,300 Added 30.76%	154,306 $1.71 Million
Q3 2018 Nov 14, 2018	SELL	$10.88 - $14.52 $195,339 - $260,692	-17,954 Reduced 13.21%	118,006 $1.31 Million
Q2 2018 Apr 21, 2020	BUY	$10.66 - $14.38 $228,038 - $307,616	21,392 Added 18.67%	135,960 $1.83 Million
Q2 2018 Aug 14, 2018	SELL	$10.66 - $14.38 $1 Million - $1.35 Million	-93,927 Reduced 45.05%	114,568 $1.54 Million
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $947,160 - $1.6 Million	105,240 Added 101.92%	208,495 $2.71 Million
Q4 2017 Feb 14, 2018	SELL	$7.67 - $9.31 $2 Million - $2.43 Million	-260,705 Reduced 71.63%	103,255 $949,000
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $2.17 Million - $3.01 Million	363,960	363,960 $2.93 Million

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account